These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16633753)
1. Impact of donor age on the growth of young recipient rats after liver transplantation. Koh M; Okamoto E; Yamanaka J; Fujimoto J Surg Today; 2006; 36(5):457-64. PubMed ID: 16633753 [TBL] [Abstract][Full Text] [Related]
2. Impact of donor gender on male rat recipients of small-for-size liver grafts. Gu Y; Dirsch O; Dahmen U; Ji Y; He Q; Chi H; Broelsch CE Liver Transpl; 2005 Jun; 11(6):669-78. PubMed ID: 15915489 [TBL] [Abstract][Full Text] [Related]
3. Immunological unresponsiveness to hepatic allografts in rats. Immunological reactivities of the recipient to donor antigens. Hasuike Y; Monden M; Valdivia LA; Kubota N; Nakano Y; Gotoh M; Okamura J; Mori T Transplantation; 1989 Jun; 47(6):1043-7. PubMed ID: 2660342 [TBL] [Abstract][Full Text] [Related]
4. Donor age and outcome of liver transplantation. Hoofnagle JH; Lombardero M; Zetterman RK; Lake J; Porayko M; Everhart J; Belle SH; Detre KM Hepatology; 1996 Jul; 24(1):89-96. PubMed ID: 8707288 [TBL] [Abstract][Full Text] [Related]
5. Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C. Machicao VI; Bonatti H; Krishna M; Aqel BA; Lukens FJ; Nguyen JH; Rosser BG; Satyanarayana R; Grewal HP; Hewitt WR; Harnois DM; Crook JE; Steers JL; Dickson RC Transplantation; 2004 Jan; 77(1):84-92. PubMed ID: 14724440 [TBL] [Abstract][Full Text] [Related]
9. Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation. Selzner M; Kashfi A; Selzner N; McCluskey S; Greig PD; Cattral MS; Levy GA; Lilly L; Renner EL; Therapondos G; Adcock LE; Grant DR; McGilvray ID Liver Transpl; 2009 Oct; 15(10):1288-95. PubMed ID: 19790152 [TBL] [Abstract][Full Text] [Related]
10. Influence of donor and recipient gender on the outcome of liver transplantation. Brooks BK; Levy MF; Jennings LW; Abbasoglu O; Vodapally M; Goldstein RM; Husberg BS; Gonwa TA; Klintmalm GB Transplantation; 1996 Dec; 62(12):1784-7. PubMed ID: 8990363 [TBL] [Abstract][Full Text] [Related]
11. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts. Khapra AP; Agarwal K; Fiel MI; Kontorinis N; Hossain S; Emre S; Schiano TD Liver Transpl; 2006 Oct; 12(10):1496-503. PubMed ID: 16964597 [TBL] [Abstract][Full Text] [Related]
12. Rejection of spontaneously accepted rat liver allografts with recipientinterleukin-2 treatment or donor irradiation. Tu Y; Arima T; Flye MW Transplantation; 1997 Jan; 63(2):177-81. PubMed ID: 9020314 [TBL] [Abstract][Full Text] [Related]
13. Use of elderly donors (> 60 years) for liver transplantation. Zhao Y; Lo CM; Liu CL; Fan ST Asian J Surg; 2004 Apr; 27(2):114-9. PubMed ID: 15140662 [TBL] [Abstract][Full Text] [Related]
14. Octogenarian liver grafts: Is their use for transplant currently justified? Jiménez-Romero C; Cambra F; Caso O; Manrique A; Calvo J; Marcacuzco A; Rioja P; Lora D; Justo I World J Gastroenterol; 2017 May; 23(17):3099-3110. PubMed ID: 28533667 [TBL] [Abstract][Full Text] [Related]
15. Age-related changes in metabolites in young donor livers and old recipient sera after liver transplantation from young to old rats. Han Q; Li H; Jia M; Wang L; Zhao Y; Zhang M; Zhang Q; Meng Z; Shao J; Yang Y; Zhu L Aging Cell; 2021 Jul; 20(7):e13425. PubMed ID: 34157207 [TBL] [Abstract][Full Text] [Related]
16. Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe. Moon JI; Kwon CH; Joh JW; Jung GO; Choi GS; Park JB; Kim JM; Shin M; Kim SJ; Lee SK Liver Transpl; 2010 Jul; 16(7):864-9. PubMed ID: 20583075 [TBL] [Abstract][Full Text] [Related]
17. Single-Center Experience Using Marginal Liver Grafts in Korea. Park PJ; Yu YD; Yoon YI; Kim SR; Kim DS Transplant Proc; 2018 May; 50(4):1147-1152. PubMed ID: 29731083 [TBL] [Abstract][Full Text] [Related]
18. Synergistic suppression of pre-perfusion of donor livers with recipient serum and cobra venom factor treatment on hyperacute rejection following liver xenotransplantation. Zhu B; Tong C; Guo W; Pu R; Zhang G; Wang L; Li M Acta Cir Bras; 2012 May; 27(5):301-5. PubMed ID: 22666742 [TBL] [Abstract][Full Text] [Related]
19. Recipient age and weight affect chronic renal allograft rejection in rats. Liu S; Lutz J; Antus B; Yao Y; Baik S; Illies F; Heemann U J Am Soc Nephrol; 2001 Aug; 12(8):1742-1749. PubMed ID: 11461948 [TBL] [Abstract][Full Text] [Related]
20. Transplantation of engineered chimeric liver with autologous hepatocytes and xenobiotic scaffold. Hata T; Uemoto S; Fujimoto Y; Murakami T; Tateno C; Yoshizato K; Kobayashi E Ann Surg; 2013 Mar; 257(3):542-7. PubMed ID: 22691372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]